Showing results (2251-2260 of 6,395) with videos related to

Sort By:
Pageof 640
Pharmaceutical Development and Technology|February 12, 2000
Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: effect of pH, capacity, tonicity, and buffer typeJ Napaporn, M Thomas, K A Svetic, et al.
Journal of Neurochemistry|April 27, 1999
Synthesis degradation, and subcellular localization of synaptotagmin IV, a neuronal immediate early gene productG D Ferguson, D M Thomas, L A Elferink, et al.
British Journal of Obstetrics and Gynaecology|February 1, 1976
The use of a computer in an obstetric departmentC S Tuck, A Cundy, H Wagman, et al.
Fertility and Sterility|January 7, 2019
Public perspectives on placing age limits on men and women seeking fertility treatmentMalinda S Lee, Leslie V Farland, Ann M Thomas, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 1, 1988
Endocrine effects of CV 205-502, a new dopamine agonist, in hyperprolactinemic womenP F van der Heijden, R Rolland, C M Thomas, et al.
Genome Biology|February 15, 2019
Skmer: assembly-free and alignment-free sample identification using genome skimsShahab Sarmashghi, Kristine Bohmann, M Thomas P Gilbert, et al.
Orphanet Journal of Rare Diseases|August 24, 2017
What can the CF registry tell us about rare CFTR-mutations? A Belgian studyE De Wachter, M Thomas, S S Wanyama, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 12, 2001
Indefinite allograft survival mediated by donor bone marrow is dependent on the presence of a functional CD95 (Fas) gene in recipientsD R Goldstein, J M Thomas, J K Kirklin, et al.
Transplantation|September 26, 2001
An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cellsD R Goldstein, J M Thomas, J K Kirklin, et al.
Pageof 640